Credit: Getty Images. The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions. Certain factors should be considered ...
New York City and New Orleans-based nonprofit dance organization gaudanse is pleased to announce that collaborating artist, ...
Hosted on MSN8d
Savara Begins FDA Submission for Rare Lung Disease TreatmentLANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has initiated the rolling submission of a Biologics License Application (BLA) to ...
New York City and New Orleans-based nonprofit dance organization gaudanse has revealed that collaborating artist, Christian ...
Jefferies analyst Andrew Tsai maintained a Buy rating on Savara (SVRA – Research Report) on December 18 and set a price target of $8.50.Pick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results